The Global Healthcare Architecture Market is likely to expand at decent pace due to recent trends in architectural design and implementation. According to a report published by Fortune Business Insights, titled “Healthcare Architecture Market Size, Share and Global Trend By Product Facility Type (Hospitals, ASCs, Long Term Care Facilities & Nursing Homes, Academic Institutes & Others), Service Type (New Construction & Refurbishment) and Geography Forecast till 2025,” the market is likely to reach US$ 8,210.5 Mn by 2025. The rise in market valuation from US$ 5,954.3 Mn indicates that the market will exhibit a CAGR of 4.1%.

The increasing geriatric population and fierce market competition have created a high demand for improved quality of patient care, which have kept healthcare architecture companies on their toes. Incorporation of automated concepts has led to a substantial rise in adoption of modern design concepts in healthcare architecture.

  • Western Europe represents approximately 25% of the global medical device market, with Germany leading the market followed by France, the UK and Italy.

  • The European medical devices market is the second largest, valued at €58 billion. The leading EU markets are Germany, France, Italy, the United Kingdom and Spain (Klass Consulting, 2015).

There is currently an abundance of promising nascent commercial stage medical technology Companies, on the international stage, but they are often stalled because of a lack of expertise in commercial  development or entering new markets, like the European one .





Italy is a mature market for medical equipment, and its high per capita income and sophisticated healthcare system translate into demand for a broad range of cutting-edge medical equipment.

Budgetary pressures and escalating costs are moving Italy towards value-based health care: new products need to provide better health outcomes in cost-effective ways. In fact, the public healthcare system is likely to develop value- and quality-based pricing models and request data and analytics for cost-effective evidence.  Opportunities for companies with very innovative products are rising compared to traditional products. Preventive care, remote monitoring and early identification of at-risk-patients are increasingly valued.

Public procurement procedures relating to the supply of Medical Devices are increasingly organized and managed by central purchasing bodies. The main central purchasing bodies act at the regional level, but attempts to introduce national centralized purchases are under way.

Because of most purchases are made by public tender , the introduction of a traditional device or equipment, although is high-quality/ high-grade, is subjected to a centralized procurement tender ; considering that a tender process requires  at least six months and that a tender is contracted for many years ( usually 3/4 ) only important multinational corporations have the economic strength to introduce or to launch on the Italian Market traditional device or equipment .


Exclusivity rights and negotiated procedure

Innovative, patented products, can qualify as being protected by exclusive rights, which in certain circumstances allows contracting authorities to have recourse to the (less burdensome) negotiated procedures under the public contracts legislation.



The Company’s business model includes the identification and evaluation of innovative medical devices and in vitro diagnostic (IVD) devices , their registration at Italian Ministry of Heath, Engaging Key Opinion Leaders (KOLs), Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy , a focused marketing business plan and commercialization with the most selected Italian Sales network.

There is currently an abundance of promising nascent commercial stage medical technology Companies, on the international stage, but they are often stalled because of a lack of expertise in commercial  development or entering new markets, like the European one.


Medical Horizons market research covers the whole spectrum of medical device areas.


We have been working for years in the hospital health business and we have a proven expertise in Diagnostic equipment, Life support equipment , Medical monitors and Therapeutic , diagnostics and monitoring, surgical consumables and disposables.


Experience has taught us to propose to the health professionals, technologically-advanced solutions that can make an effective contribution to solving the problems that they have to address every day.


Medical devices can be marketed in Europe after obtaining the CE certification, which guarantees that they are compliant with the essential requirements established by the European legislation. CE certification is issued by an accredited Notified Body, with the only exception of class I medical devices (non-sterile and without measuring function) that can be certified directly by the Manufacturer in view of their low risk.

In Italy, the Manufacturer (or its authorized representative in Europe) must register the medical devices in a dedicated database of the Ministry of Health before they are put into the market. The same requirement applies also to medical device kits, that must be registered into the same database by the Assembler. The data entry can be delegated to a third party.

Medical Horizons is able to help and assist your Company in obtaining the CE certification and register your product in the database of the Italian Ministry of Health so that it can be place in market for sale.


Medical Horizons recognizes that ethical interactions between the medical device and diagnostics industry and healthcare professionals advance medical technologies and ensure public confidence in the Medical Device industry. The purpose of our Code is to facilitate ethical interactions between Companies that develop, manufacture, sell, market or distribute Medical Technologies in our area of responsibility and Healthcare Professionals .

Interactions with Health Care Professionals.

Ethical interactions between Companies and Healthcare Professionals enhance patient access to the safe and effective use of Medical Technologies by ensuring appropriate training of Healthcare Professionals by Companies. Ethical interactions also promote innovation and the ongoing development of advanced Medical Technologies through legitimate and transparent collaboration between Healthcare Professionals and Companies. Further, ethical interactions facilitate open and transparent business environments free from the high costs of corruption, enhancing the ability of Companies to participate in global markets.